Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

CMS proposes major TAVR changes | The real impact of RVU cuts in electrophysiology | Girl’s heart valve implanted upside down

News You Need to Know Today
CMS proposes major TAVR changes | The real impact of RVU cuts in electrophysiology | Girl’s heart valve implanted upside down
Wednesday, June 17, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

CMS proposes major TAVR changes, including Medicare coverage for asymptomatic patients

After months of consideration, CMS has proposed sweeping changes to its TAVR coverage policies. The agency is accepting public comments until July 15.

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

CMS proposes major TAVR changes, including Medicare coverage for asymptomatic patients

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
After months of consideration, CMS has proposed sweeping changes to its TAVR coverage policies. The agency is accepting public comments until July 15.
READ MORE >

'Not sustainable': The real impact of RVU cuts in electrophysiology

Despite a substantial increase in demand for electrophysiologists, payments for their services have remained stagnant. 

READ MORE >
Joshua R. Silverstein, MD, FHRS, a cardiac electrophysiologist at Allegheny Health Network Cardiovascular Institute, explains the real-world impacts of Centers of Medicare and Medicaid Services (CMS) RVU cuts in electrophysiology.
Share on Twitter Share on Facebook Share on Linkedin

'Not sustainable': The real impact of RVU cuts in electrophysiology

Share on Twitter Share on Facebook Share on Linkedin
Joshua R. Silverstein, MD, FHRS, a cardiac electrophysiologist at Allegheny Health Network Cardiovascular Institute, explains the real-world impacts of Centers of Medicare and Medicaid Services (CMS) RVU cuts in electrophysiology.
Despite a substantial increase in demand for electrophysiologists, payments for their services have remained stagnant. 
READ MORE >

Family files $17M lawsuit after young girl’s heart valve allegedly implanted upside down

Days went by and the girl's doctors never figured out what was wrong. When she was transferred to a different hospital, however, the issue was quickly identified and corrected. 

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Family files $17M lawsuit after young girl’s heart valve allegedly implanted upside down

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
Days went by and the girl's doctors never figured out what was wrong. When she was transferred to a different hospital, however, the issue was quickly identified and corrected. 
READ MORE >

Featured Articles

Plaque imaging, AI and structural heart disease in the spotlight at SCCT 2026 meeting

Coronary plaque imaging is an area many experts believe is driving a shift toward earlier detection and prevention of heart disease.

READ MORE >
Ronen Rubinshtein, MD, FACC, FESC, director, heart institute, Edith Wolfson Medical Center, in Holon, Israel, president elect for the Society of Cardiovascular Computed Tomography (SCCT), and chairman of the SCCT 2026 annual scientific meeting, explains plaque imaging, AI and structural heart disease are the spotlight at the meeting.
Share on Twitter Share on Facebook Share on Linkedin

Plaque imaging, AI and structural heart disease in the spotlight at SCCT 2026 meeting

Share on Twitter Share on Facebook Share on Linkedin
Ronen Rubinshtein, MD, FACC, FESC, director, heart institute, Edith Wolfson Medical Center, in Holon, Israel, president elect for the Society of Cardiovascular Computed Tomography (SCCT), and chairman of the SCCT 2026 annual scientific meeting, explains plaque imaging, AI and structural heart disease are the spotlight at the meeting.
Coronary plaque imaging is an area many experts believe is driving a shift toward earlier detection and prevention of heart disease.
READ MORE >

Medline recalls nearly 50K procedure kits, including many used by cardiologists

This recall was put in place due to a risk of the included adhesive not working. Nothing needs to be returned, but clinicians should not use the adhesive that comes inside the procedure kits.

READ MORE >
the words "FDA recall" on a board
Share on Twitter Share on Facebook Share on Linkedin

Medline recalls nearly 50K procedure kits, including many used by cardiologists

Share on Twitter Share on Facebook Share on Linkedin
the words "FDA recall" on a board
This recall was put in place due to a risk of the included adhesive not working. Nothing needs to be returned, but clinicians should not use the adhesive that comes inside the procedure kits.
READ MORE >

Looking ahead to the future of FFR-CT

Current research suggests this technology is just getting started when it comes to transforming patient care.

READ MORE >
An example of the image quality from the new GE Photonova photon-counting CT system, where more detailed images of soft plaque and the ability to see through heavy calcium and stents is expected to improve CT-FFR assessments.
Share on Twitter Share on Facebook Share on Linkedin

Looking ahead to the future of FFR-CT

Share on Twitter Share on Facebook Share on Linkedin
An example of the image quality from the new GE Photonova photon-counting CT system, where more detailed images of soft plaque and the ability to see through heavy calcium and stents is expected to improve CT-FFR assessments.
Current research suggests this technology is just getting started when it comes to transforming patient care.
READ MORE >

Medtronic completes $550M acquisition of neurovascular company

Scientia Vascular, a medtech company focused on advanced stroke therapies, is now officially part of Medtronic. 

READ MORE >
business partnership handshake merger acquisition M&A
Share on Twitter Share on Facebook Share on Linkedin

Medtronic completes $550M acquisition of neurovascular company

Share on Twitter Share on Facebook Share on Linkedin
business partnership handshake merger acquisition M&A
Scientia Vascular, a medtech company focused on advanced stroke therapies, is now officially part of Medtronic. 
READ MORE >

In Case You Missed It

'Compelling' study shows promise of new pulmonary embolectomy system

"Pulmonary embolism is fundamentally a cardiovascular disease, where restoration of hemodynamic stability, beyond simple clot removal, is the key determinant of patient recovery,” one researcher explained. 

READ MORE >
Jupiter Endovascular's Vertex Pulmonary Embolectomy System showed positive results in its SPIRARE II pivotal trial.
Share on Twitter Share on Facebook Share on Linkedin

'Compelling' study shows promise of new pulmonary embolectomy system

Share on Twitter Share on Facebook Share on Linkedin
Jupiter Endovascular's Vertex Pulmonary Embolectomy System showed positive results in its SPIRARE II pivotal trial.
"Pulmonary embolism is fundamentally a cardiovascular disease, where restoration of hemodynamic stability, beyond simple clot removal, is the key determinant of patient recovery,” one researcher explained. 
READ MORE >

Artivion acquires medtech company behind FDA-approved endovascular device for $135M

The purchase price could end up being closer to $200 million if certain commercial milestones are met.

READ MORE >
Nexus Aortic Arch System Artivion Endospan
Share on Twitter Share on Facebook Share on Linkedin

Artivion acquires medtech company behind FDA-approved endovascular device for $135M

Share on Twitter Share on Facebook Share on Linkedin
Nexus Aortic Arch System Artivion Endospan
The purchase price could end up being closer to $200 million if certain commercial milestones are met.
READ MORE >

Shockwave Medical's new IVL catheter overcomes previous limitations

Ziad Ali, MD, said the new device has completely changed the way he and his colleagues treat patients with calcified coronary artery disease. 

READ MORE >
Ziad Ali, MD, DPhil, director of the DeMatteis Cardiovascular Institute, St. Francis Hospital and Heart Center, spoke with Cardiovascular Business about his center's experience using the recently released Johnson & Johnson MedTech next-generation Shockwave C2 Aero Coronary IVL Catheter to treat calcified coronary artery disease. Ali said his center was the first in the world to use the catheter in August 2025 and has since gained experience in roughly 80 cases.
Share on Twitter Share on Facebook Share on Linkedin

Shockwave Medical's new IVL catheter overcomes previous limitations

Share on Twitter Share on Facebook Share on Linkedin
Ziad Ali, MD, DPhil, director of the DeMatteis Cardiovascular Institute, St. Francis Hospital and Heart Center, spoke with Cardiovascular Business about his center's experience using the recently released Johnson & Johnson MedTech next-generation Shockwave C2 Aero Coronary IVL Catheter to treat calcified coronary artery disease. Ali said his center was the first in the world to use the catheter in August 2025 and has since gained experience in roughly 80 cases.
Ziad Ali, MD, said the new device has completely changed the way he and his colleagues treat patients with calcified coronary artery disease. 
READ MORE >

In Other News

Healthcare AI vendor suffers data breach, exposing patient records to hackers

Tennessee-based Xsolis said the incident occurred in January, and the sensitive data was from its clients. The company provides AI-powered case management software to hospitals and health insurers.

READ MORE >
Phishing Hack Data Breach Password
Share on Twitter Share on Facebook Share on Linkedin

Healthcare AI vendor suffers data breach, exposing patient records to hackers

Share on Twitter Share on Facebook Share on Linkedin
Phishing Hack Data Breach Password
Tennessee-based Xsolis said the incident occurred in January, and the sensitive data was from its clients. The company provides AI-powered case management software to hospitals and health insurers.
READ MORE >

FDA approves Bayer's new low-dose gadolinium imaging agent

Coming in at just 0.04 mmol gadolinium per kilogram body weight, gadoquatrane has 60% less gadolinium than the lowest dose GBCA currently on the market.

READ MORE >
carestream_3.jpg
Share on Twitter Share on Facebook Share on Linkedin

FDA approves Bayer's new low-dose gadolinium imaging agent

Share on Twitter Share on Facebook Share on Linkedin
carestream_3.jpg
Coming in at just 0.04 mmol gadolinium per kilogram body weight, gadoquatrane has 60% less gadolinium than the lowest dose GBCA currently on the market.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

CMS proposes major TAVR changes | The real impact of RVU cuts in electrophysiology | Girl’s heart valve implanted upside down
News Alert: CMS proposes major TAVR changes
Cath lab kits recalled | Looking ahead to the future of FFR-CT | Medtronic completes major acquisition
FDA sees potential in heart failure software | SCCT & SCAI take on CT-derived FFR | Predicting long-term stroke risk
Abbott recalls heart monitoring tech | Redo TAVR with balloon-expandable valves | FDA clears new clot-removing device
Week in Review: Star Trek star's family awarded $13M | AI for cardiac amyloidosis | TAVR concerns | New CKM syndrome guidelines
A brand new payment model | Cardiologist compensation keeps rising | Major medtech player invests $1.5B in TAVR tech

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup